Explore

Trendline Trendline
Atossa Therapeutics' Endoxifen Trial Shows Promise in Reducing Breast Cancer Risk

Atossa Therapeutics' Endoxifen Trial Shows Promise in Reducing Breast Cancer Risk

Atossa Therapeutics' Endoxifen Trial Shows Promise in Reducing Breast Cancer Risk
Trendline Trendline
Arrowhead Pharmaceuticals Licenses MASH Program to Madrigal Pharmaceuticals

Arrowhead Pharmaceuticals Licenses MASH Program to Madrigal Pharmaceuticals

Arrowhead Pharmaceuticals Licenses MASH Program to Madrigal Pharmaceuticals
Trendline Trendline
GSK Licenses siRNA Drug from China's SiranBio in $1 Billion Deal to Target Cardiometabolic Diseases

GSK Licenses siRNA Drug from China's SiranBio in $1 Billion Deal to Target Cardiometabolic Diseases

GSK Licenses siRNA Drug from China's SiranBio in $1 Billion Deal to Target Cardiometabolic Diseases
Trendline Trendline
Kanvas Biosciences Secures $48 Million to Advance Microbiome Therapeutics for Cancer Patients

Kanvas Biosciences Secures $48 Million to Advance Microbiome Therapeutics for Cancer Patients

Kanvas Biosciences Secures $48 Million to Advance Microbiome Therapeutics for Cancer Patients
Trendline Trendline
DiaMedica Therapeutics Reports Financial Results and Advances Clinical Trials for Preeclampsia and Stroke

DiaMedica Therapeutics Reports Financial Results and Advances Clinical Trials for Preeclampsia and Stroke

DiaMedica Therapeutics Reports Financial Results and Advances Clinical Trials for Preeclampsia and Stroke
Trendline Trendline
Kanvas Biosciences Secures $48M to Enhance Spatial Biology and Cancer Trials

Kanvas Biosciences Secures $48M to Enhance Spatial Biology and Cancer Trials

Kanvas Biosciences Secures $48M to Enhance Spatial Biology and Cancer Trials
Trendline Trendline
Vertex Honored with 2026 Kidney Biotech Innovation Award by National Kidney Foundation

Vertex Honored with 2026 Kidney Biotech Innovation Award by National Kidney Foundation

Vertex Honored with 2026 Kidney Biotech Innovation Award by National Kidney Foundation
Trendline Trendline
Vertex Pharmaceuticals Prepares for Potential Breakthrough in Renal Treatment with Povetacicept

Vertex Pharmaceuticals Prepares for Potential Breakthrough in Renal Treatment with Povetacicept

Vertex Pharmaceuticals Prepares for Potential Breakthrough in Renal Treatment with Povetacicept
Trendline Trendline
Cytokinetics to Release Phase 3 Trial Results for Aficamten in Heart Disease Treatment

Cytokinetics to Release Phase 3 Trial Results for Aficamten in Heart Disease Treatment

Cytokinetics to Release Phase 3 Trial Results for Aficamten in Heart Disease Treatment
Trendline Trendline
Pharmaceutical Leaders Utilize Protein Biomarkers to Mitigate Drug Development Risks

Pharmaceutical Leaders Utilize Protein Biomarkers to Mitigate Drug Development Risks

Pharmaceutical Leaders Utilize Protein Biomarkers to Mitigate Drug Development Risks
Trendline Trendline
ISOThrive Announces Positive Phase 2 Results for MHS-1031 in NERD Patients

ISOThrive Announces Positive Phase 2 Results for MHS-1031 in NERD Patients

ISOThrive Announces Positive Phase 2 Results for MHS-1031 in NERD Patients
Trendline Trendline
Mapi Pharma Plans U.S. Aseptic Manufacturing Facility to Meet Growing Demand for Injectables

Mapi Pharma Plans U.S. Aseptic Manufacturing Facility to Meet Growing Demand for Injectables

Mapi Pharma Plans U.S. Aseptic Manufacturing Facility to Meet Growing Demand for Injectables